Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03481556
Title Study of Melflufen + Dex With Bortezomib or Daratumumab in Patients With RRMM (ANCHOR)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Oncopeptides AB
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

No variant requirements are available.